CDC Recommends Pfizer and Moderna COVID-19 Boosters for All US Adults
The US Centers for Disease Control and Prevention (CDC) has recommended the use of COVID-19 vaccine boosters for everyone 18
Read more
COVID-19
Coronavirus (COVID-19) pharmaceutical industry updates
Read the latest pharmaceutical industry press releases, news updates and articles on coronavirus COVID-19 medical treatment, therapies and drug and vaccine development.
Emergex to Launch Phase I Trial for New T-Cell Priming COVID-19 Vaccine
A next-generation COVID-19 vaccine, developed by British biotech Emergex, designed to prime T-Cells to rapidly remove viral-infected cells and offer
Read more
Japan to Buy 1.6 Mill Courses of Merck’s Oral COVID-19 Antiviral Molnupiravir
Merck (MRK) and Ridgeback Biotherapeutics have announced that the Japanese government will acquire approximately 1.6 million courses of molnupiravir (MK-4482,
Read more
J&J to Provide its One Dose COVID-19 Vaccine to the Most Vulnerable via COVAX Humanitarian Buffer
The world’s most vulnerable populations are given access to COVID-19 vaccines thanks to the COVAX Humanitarian Buffer. Johnson & Johnson
Read more
Pfizer’s COVID-19 Oral Antiviral Candidate 89% Effective in Phase 2/3 Study
The novel COVID-19 investigational oral antiviral treatment PAXLOVID™ (PF-07321332; ritonavir) by Pfizer, was found to reduce the risk of hospitalization
Read more
First Oral COVID-19 Antiviral Medicine Approved in the UK
Merck and Ridgeback’s Molnupiravir has become the world’s first approved oral COVID-19 antiviral drug. Molnupiravir has been authorised by the
Read more
FDA Panel in Favor of Pfizer’s COVID-19 Vaccine for Children Aged 5 to 12
The U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) has voted 17 to 0,
Read more
Valneva’s COVID-19 Vaccine Candidate Shows Positive Results in Phase 3 Trial
French pharmaceutical company Valneva has reported positive results for its inactivated, adjuvanted COVID-19 vaccine candidate VLA2001 in the Phase 3
Read more
FDA Expands Use of COVID-19 Vaccine Booster Dose in Eligible Populations
The US Food and Drug Administration has granted approval for administration of COVID-19 vaccine booster dosage, upgrading the emergency use
Read more
Merck and Ridgeback’s Oral Antiviral Molnupiravir Can Halve COVID-19 Risk of Hospitalisation
Interim Analysis of Phase 3 Study shows Merck and Ridgeback’s investigational oral antiviral Molnupiravir has reduced the risk of hospitalization
Read more